3 November 2012
Skin cancer pill looks positive
The skin cancer pill, Zelboraf, has received positive guidance from The National Institute for Health and Clinical Excellence (NICE).
The Institute hace recommended Zelboraf for the treatment of BRAF mutation positive unresectable ...